Trade Mark Journal No.2025/039 26 September 2025
WO0000001874655 (5)
Office of origin: United States of America
Date of International Registration:5 August 2025
Date of designation in the UK:
5 August 2025

The mark consists of the text "ELZONRIS" preceded by the stylized design of a circle open at the top with a series of three, two-dimensional inverted "V" shapes extending downwards and into the middle of the circle.
International priority date claimed: 28 May 2025
(United States of America)
(99206080)
- Class 5
- Anti-cancer preparations.
Stemline Therapeutics, Inc.
Representative: Maury M Tepper, III Tepper & Eyster, PLLC, 3724 Benson Drive, Raleigh NC 27609, UNITED STATES OF AMERICA